Loading…
Loading…
Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
Lipton, Richard B., Serrano, Daniel, Nicholson, Robert A., Buse, Dawn C., Runken, M. Chris, Reed, Michael L.
Published in Headache (01.11.2013)
Published in Headache (01.11.2013)
Get full text
Journal Article
Loading…
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks
Gomez-Mancilla, Baltazar, Brand, Ronald, Jürgens, Tim P, Göbel, Harmut, Sommer, Claudia, Straube, Andreas, Evers, Stefan, Sommer, Martin, Campos, Victor, Kalkman, Hans O, Hariry, Sam, Pezous, Nicole, Johns, Donald, Diener, Hans-Christoph
Published in Cephalalgia (01.02.2014)
Published in Cephalalgia (01.02.2014)
Get full text
Journal Article
Loading…
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine
Cady, Roger K., Munjal, Sagar, Cady, Ryan J., Manley, Heather R., Brand-Schieber, Elimor
Published in Journal of headache and pain (01.12.2017)
Published in Journal of headache and pain (01.12.2017)
Get full text
Journal Article
Loading…
Loading…
Loading…
Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study
Edwards, John, Sperry, Vasi, Adams, Marijke H, Gallipoli, Susan, Thorn, Michael D, Longstreth, James, Boinpally, Ramesh
Published in International journal of clinical pharmacology and therapeutics (01.06.2013)
Published in International journal of clinical pharmacology and therapeutics (01.06.2013)
Get more information
Journal Article